Sort by:

select Language:


Counterfeit drugs and medical devices in developing countries

Beverly D Glass, (2014)

The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information on their impact and how these issues can be addressed by regulation and control of the supply chain using technology appropriate to the developing world.

Counterfeit Drugs - Guidelines for the development of measures to combat counterfeit medicines

World Health Organization, (1999)

These guidelines are aimed to provide guidance to Member States in developing their own national measures to combat counterfeiting of medicines. The guidelines include: an overview of the problems and factors concerning the counterfeiting of medicines; important steps to be followed in developing national strategies; inspection and screening of suspected counterfeit medicines; training of human resources.

12 hits